Glycosides for Peripheral Neuropathic Pain: A Potential Medicinal Components
Open Access
Abstract
Neuropathic pain is a refractory disease that occurs across the world and pharmacotherapy has limited efficacy and/or safety. This disease imposes a significant burden on both the somatic and mental health of patients; indeed, some patients have referred to neuropathic pain as being ‘worse than death’. The pharmacological agents that are used to treat neuropathic pain at present can produce mild effects in certain patients, and induce many adverse reactions, such as sedation, dizziness, vomiting, and peripheral oedema. Therefore, there is an urgent need to discover novel drugs that are safer and more effective. Natural compounds from medical plants have become potential sources of analgesics, and evidence has shown that glycosides alleviated neuropathic pain via regulating oxidative stress, transcriptional regulation, ion channels, membrane receptors and so on. In this review, we summarize the epidemiology of neuropathic pain and the existing therapeutic drugs used for disease prevention and treatment. We also demonstrate how glycosides exhibit an antinociceptive effect on neuropathic pain in laboratory research and describe the antinociceptive mechanisms involved to facilitate the discovery of new drugs to improve the quality of life of patients experiencing neuropathic pain.Keywords
Funding Information
- Yu-Xiang Li (81960726)
- Ning Liu (2019AAC03097)
- Xiao-Bing Lan (2021AAC03139)
This publication has 152 references indexed in Scilit:
- Characterizing the cytoprotective activity of Sarracenia purpurea L., a medicinal plant that inhibits glucotoxicity in PC12 cellsBMC Complementary and Alternative Medicine, 2012
- Matrix Metalloproteinases in Neuropathic Pain and Migraine: Friends, Enemies, and Therapeutic TargetsPain Research and Treatment, 2012
- Prevalence and comorbidity of chronic pain in the German general populationJournal of Psychiatric Research, 2012
- Spatial and temporal activation of spinal glial cells: Role of gliopathy in central neuropathic pain following spinal cord injury in ratsExperimental Neurology, 2012
- Activation of endothelial TRPV4 channels mediates flow-induced dilation in human coronary arterioles: role of Ca2+ entry and mitochondrial ROS signalingAmerican Journal of Physiology-Heart and Circulatory Physiology, 2012
- Acute Cold Hypersensitivity Characteristically Induced by Oxaliplatin is Caused by the Enhanced Responsiveness of TRPA1 in MiceMolecular Pain, 2012
- The epidemiology of chronic pain in children and adolescents revisited: A systematic reviewPain, 2011
- Use of complementary and alternative medicine by those with a chronic disease and the general population - results of a national population based surveyBMC Complementary and Alternative Medicine, 2010
- Transient receptor potential channels: targeting pain at the sourceNature Reviews Drug Discovery, 2009
- Glucose and GLP-1 Stimulate cAMP Production via Distinct Adenylyl Cyclases in INS-1E Insulinoma CellsJournal of General Physiology, 2008